Literature DB >> 23589195

Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.

Anne-Marie Ternes1, Jerome J Maller, Joanne Fielding, Patricia Addamo, Owen White, Nellie Georgiou-Karistianis.   

Abstract

The corpus callosum (CC) is commonly affected in multiple sclerosis (MS), however, sensitive behavioral measures of MS-related CC pathology are lacking. The CC is considered a key structure in the mediation of a type of involuntary movement known as motor overflow. In this study, we sought to characterize the impact of CC damage on motor overflow in MS. Twenty MS participants and 20 controls performed a unilateral force production task. Motor overflow (involuntary force) in the non-active hand was measured while the active hand performed the task. CC volume and lesion load were calculated for MS participants using T2-weighted MRI. We found no group differences in motor overflow; however, motor overflow correlated significantly with MS disease severity [Expanded disability status scale (EDSS)]. CC damage (lesions and decreased volume) did not correlate with motor overflow. This study suggests that CC damage may not directly lead to changes in the regulation of motor overflow. Rather, findings support the notion that a wider network of structures may mediate the production and suppression of motor overflow.

Entities:  

Mesh:

Year:  2013        PMID: 23589195     DOI: 10.1007/s00415-013-6914-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

1.  Sex differences in the corpus callosum of patients with schizophrenia.

Authors:  Matthew S Panizzon; Anne L Hoff; Thomas E Nordahl; William S Kremen; Barbara Reisman; Mary Wieneke; Debra Harris; Chris Goodman; Scott Espinoza; William Liu; Kelvin Lim
Journal:  Schizophr Res       Date:  2003-07-01       Impact factor: 4.939

2.  Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.

Authors:  X Lin; C R Tench; P S Morgan; C S Constantinescu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-02       Impact factor: 10.154

3.  Interhemispheric motor inhibition: its role in controlling electromyographic mirror activity.

Authors:  Annemarie Hübers; Yuriy Orekhov; Ulf Ziemann
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

Review 4.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

Review 5.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

6.  Supplementary motor area of the monkey's cerebral cortex: short- and long-term deficits after unilateral ablation and the effects of subsequent callosal section.

Authors:  C Brinkman
Journal:  J Neurosci       Date:  1984-04       Impact factor: 6.167

7.  Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: a functional and anatomical study.

Authors:  Delia Lenzi; Antonella Conte; Caterina Mainero; Vittorio Frasca; Federica Fubelli; Porzia Totaro; Francesca Caramia; Maurizio Inghilleri; Carlo Pozzilli; Patrizia Pantano
Journal:  Hum Brain Mapp       Date:  2007-07       Impact factor: 5.038

8.  Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis.

Authors:  J Pelletier; M Habib; O Lyon-Caen; G Salamon; M Poncet; R Khalil
Journal:  Arch Neurol       Date:  1993-10

9.  Motor overflow in schizophrenia.

Authors:  Kate E Hoy; Paul B Fitzgerald; John L Bradshaw; Maree Farrow; Timothy L Brown; Christine A Armatas; Nellie Georgiou-Karistianis
Journal:  Psychiatry Res       Date:  2004-02-15       Impact factor: 3.222

10.  Morphology of the corpus callosum in treatment-resistant schizophrenia and major depression.

Authors:  J Sun; J J Maller; Z J Daskalakis; C C Furtado; P B Fitzgerald
Journal:  Acta Psychiatr Scand       Date:  2009-04-20       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.